Hims & Hers to Offer Wegovy at $249/Month Subscription Plans
Hims & Hers will join Novo Nordisk’s Wegovy subscription program, offering eligible self-pay patients three-, six- or 12-month plans where a 12-month injection or pill subscription costs $249/month and saves up to $1,200 annually. Flat monthly pricing across dose changes could drive patient retention and telehealth sales for the company.
1. Partnership Details
Novo Nordisk expanded its Wegovy subscription program on March 31, listing Ro, WeightWatchers and LifeMD as initial providers and confirming that Hims & Hers will join soon alongside Sesame. Hims & Hers will enable patients to enroll in multi-month plans via its platform, broadening treatment access.
2. Subscription Pricing Structure
The program offers three-, six- or 12-month subscriptions, with the longest plan priced at $249 per month for both injection and pill versions, delivering up to $1,200 in annual savings on injections and $600 on pills. Subscribers enjoy fixed monthly costs regardless of dose adjustments through the commitment period.
3. Financial and Strategic Implications
By adding Wegovy to its service offerings, Hims & Hers may capture part of the growing GLP-1 market and bolster telehealth revenue streams as patients seek affordable, consistent obesity treatments. The partnership could enhance customer retention and expand Hims & Hers’s healthcare portfolio amid intensifying competition in digital therapeutics.